November 21, 2025- Our research article is published on PNAS, reporting the targeting of orthotopic and metastatic pancreatic cancer with allogeneic stem cell-engineered mesothelin-redirected CAR-NKT cells. This study is in collaboration with the Caius Radu Lab at UCLA. Congratulations to […]
November 18, 2025- Our PhD student, James Elsten-Brown, receives the distinguished John W. Phillips Legacy Award that recognizes exceptional achievements in research, teaching, and mentoring. Congratulations! [UCLA MIMG News PDF] June 10, 2025- Our PhD student, John Yichen Zhu, receives […]
May 30, 2024- Dr. Lili Yang receives a $6.3 million CIRM Partnering Opportunity for Translational Research Projects Award to translate a novel stem cell-engineered off-the-shelf CAR-NKT cell therapy for ovarian cancer into clinics. [Link][PDF] May 18, 2021- Dr. Lili Yang […]
We are currently recruiting PhD students (2 openings) and postdoctoral researchers (1 opening). Welcome to apply! [PhD Openings][Postdoc Openings]
May 11, 2021- Our off-the-shelf cell therapy technology is licensed by a Biotech startup, Appia Bio, for commercial development. The company launches with $52 million Series A financing. [Appia News][Endpoints News] August 5, 2021- Appia Bio and Kite announce collaboration […]
